12.04.2011 • News

Merck KGaA Eyes Job Cuts at Drugs Unit

Germany's Merck KGaA  is mulling job cuts at prescription drug unit Merck Serono to save costs, the Financial Times Deutschland newspaper reported, citing company sources.

Cutbacks could affect the unit's Swiss headquarters in particular, the paper added.

Stefan Oschmann took over Merck's prescription drug unit Merck Serono on Jan. 1 after the unit saw a string of setbacks in product development.

The European drugs watchdog on Sept. 24 dealt the German family controlled group a blow by advising against the oral multiple-sclerosis treatment cladribine in the drug's potentially largest market.

Global drugmakers, including Merck & Co, Roche and Novartis, have announced job cuts as approvals for new products are slowing while key drugs are losing patent protection.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.